The Indian pharmaceutical sector showed a downward trend in early trading on March 13, 2026, aligning with broader market weakness. The S&P BSE Healthcare Index stood at 43,441.0, down 0.6% at the time of the update (around 09:42 AM IST for BSE prices). Over the past 30 days, the index had gained 0.6%, while it was up 10.5% over the last year.
The benchmark S&P BSE Sensex was at 75,469.77 to 75,469.8, down approximately 0.7%. Related indices like Nifty Pharma closed the previous day (March 12, 2026) around 23,275.20, down 0.31%, reflecting similar pressure in the sector.
Pharma Stocks Performance Snapshot (as of March 13, 2026, early morning)
Data reflects BSE and NSE prices with percentage changes at approximately 09:42 AM IST (BSE) and 09:44:59 AM IST (NSE). Most stocks traded lower, with declines ranging from minor to over 2-4% in several cases.
- Sun Pharma: BSE 1,830.95 (+0.33%), NSE 1,826.80 (+0.08%) — one of the few with slight positive movement.
- Torrent Pharma: BSE 4,451.50 (+0.15%), NSE 4,457.80 (+0.27%).
- IPCA Labs: BSE 1,562.30 (+0.18%), NSE 1,565.00 (+0.27%).
- Alkerm Laboratories: BSE 5,452.00 (+0.08%), NSE 5,448.00 (+0.07%).
- Syngene International: +5.20% on both exchanges (notable gainer in the list).
- Supriya Lifescience: +2.23% BSE, +2.40% NSE.
- Innova Captab Ltd.: +1.15% BSE, +0.99% NSE.
Many large and mid-cap names declined:
- Ajanta Pharma: BSE 3,063.60 (-1.88%), NSE 3,066.80 (-1.69%).
- Laurus Labs: BSE 1,021.65 (-2.31%), NSE 1,020.00 (-2.56%).
- Granules India: BSE 574.05 (-2.14%), NSE 575.50 (-1.92%).
- Neuland Labs: 12,325.00 (-1.94% to -1.98%).
- Jubilant Industries: -4.08% to -4.46% (among steeper drops).
- SMS Pharma: -3.38% to -4.21%.
Other notable names like Cipla (-0.17% to -0.19%), Dr. Reddy’s (-0.27% to -0.52%), Divi’s Laboratories (-0.50% to -0.64%), and Lupin (-0.14%) saw minor declines.
Sector Gainers and Losers Context
Within the broader pharmaceuticals sector (including smaller stocks), top gainers included Fervent Synergies (up 12.2%) and Tejnaksh Healthcare (up 8.0%). Top losers featured Dr. Habeebullah Life Sciences (down 9.5%) and Rubra Medica (down 4.7%).
This update captures intraday levels from early March 13, 2026 trading. Pharma sector performance can be influenced by factors like US generics pricing pressures, domestic formulations growth, and global events, as seen in recent analyses of Q3 FY26 results and outlook for 2026.
For real-time quotes, check official exchanges (BSE/NSE) or financial platforms, as prices fluctuate throughout the day.
Also read: Power sector stocks today, March 13: NTPC Green rally 6.83%, Adani Power up 1.81%, Power Grid surge 1.23%